2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU). (September 2015) - De La Motte Rouge, T.; Pautier, P.; Alexandre, J.; Ray-Coquard, I.; Cottu, P.; Rodrigues, M.; Follana, P.; Floquet, A.; Lortholary, A.; Heudel, P.E.; Combe, P.; Joly, F.; et al.